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As we all know, in 2006, the Journal of Neuroimmune Pharmacology (JNIP), the official Journal of the Society on NeuroImmune Pharmacology, stepped onto the research publishing stage. JNIP has gained substantial momentum in recent years and occupies an important niche by successfully interfacing the disciplines of immunology, pharmacology, and experimental neuroscience. It has diligently acted as a platform for research discoveries and for the society in focusing on the pathogenesis and pharmacology of nervous system disorders affecting the immune system and vice versa.
Over the past 12 years, together we have published both timely reviews and cutting-edge research. Publication of these articles would not be possible without the support of our editorial board and over 1300 volunteer reviewers. Your expertise and skills provide us important peer reviews of manuscripts bringing us all to the next level.
On behalf of the journal, we thank our editorial board and reviewers for their diligence, integrity, and quality of peer reviews over the years. Your support continues to impact us all.
And, a special thank you to our authors. Your hard work and contributions to JNIP continue to move the field forward.
We look forward to the coming years -the best is yet to come.
